|
YWHAQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46490042318703E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50120005315557E-09 |
| Normal-vs-Stage2 |
2.15510000001196E-06 |
| Normal-vs-Stage3 |
1.13989999661612E-08 |
| Normal-vs-Stage4 |
1.61190000236289E-08 |
| Stage1-vs-Stage2 |
4.001200E-01 |
| Stage1-vs-Stage3 |
6.188200E-01 |
| Stage1-vs-Stage4 |
2.592200E-01 |
| Stage2-vs-Stage3 |
6.762800E-01 |
| Stage2-vs-Stage4 |
8.605200E-01 |
| Stage3-vs-Stage4 |
5.036400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.57299983938719E-10 |
| Normal-vs-AfricanAmerican |
1.634260E-02 |
| Normal-vs-Asian |
1.27979999997585E-06 |
| Caucasian-vs-AfricanAmerican |
1.113420E-01 |
| Caucasian-vs-Asian |
9.520000E-01 |
| AfricanAmerican-vs-Asian |
1.369380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.25420002056376E-09 |
| Normal-vs-Female |
3.47780026999089E-10 |
| Male-vs-Female |
6.639400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.23110000264049E-08 |
| Normal-vs-Age(41-60Yrs) |
4.37570002453924E-09 |
| Normal-vs-Age(61-80Yrs) |
2.66130006920662E-10 |
| Normal-vs-Age(81-100Yrs) |
3.898000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.995800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.837800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.150200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.995400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.700800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.950000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.495200E-01 |
| Classical-VS-Follicular |
2.25019999999798E-05 |
| Classical-VS-Other |
4.154800E-01 |
| Classical-VS-Normal |
4.27849999984353E-07 |
| Tall-VS-Follicular |
1.984100E-02 |
| Tall-VS-Other |
4.775800E-01 |
| Tall-VS-Normal |
2.999200E-04 |
| Follicular-VS-Other |
5.871200E-01 |
| Follicular-VS-Normal |
2.12020401235691E-11 |
| Other-VS-Normal |
5.476300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.01576558065153E-12 |
| Normal-vs-N1 |
1.65970015508776E-10 |
| N0-vs-N1 |
1.742600E-01 |
|
|
